Clinical Trial

The FLARE (Flurpiridaz vs. Rubidium Evaluation) Trial

Name: The FLARE (Flurpiridaz vs. Rubidium Evaluation) Trial — clinical trial record (NCT07761728)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: FLARE

Recruiting

View on ClinicalTrials.gov →

Summary

This study seeks to evaluate if the diagnostic performance of 18F-flurpiridaz positron emission tomography (PET) myocardial perfusion imaging (MPI), given the radiotracer's properties, is non-inferior to the currently most widely utilized PET MPI radiopharmaceutical, 82Rb-chloride.

Trial Details

NCT Number	NCT07761728
Lead Sponsor	University of California, Los Angeles Collaborators: VA Greater Los Angeles Healthcare System
Conditions	Coronary Artery Disease, Coronary Microvascular Disease
Enrollment	60 participants
Start Date	2025-08-13
Primary Completion	2026-12 (estimated)
Study Completion	2027-01 (estimated)
Updated on ClinicalTrials.gov	2026-08-12